MiR ‐5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6
In conclusion, our results suggest that miR‐5100 increases the cisplatin resistance of the LCSCs by inhibiting the Rab6. This study provides novel insight into the regulation of LCSCs by miRNA. This article is protected by copyright. All rights reserved
Source: Molecular Carcinogenesis - Category: Molecular Biology Authors: Lawei Yang, Ziying Lin, Yahong Wang, Shenglan Gao, Qinglan Li, Chunyan Li, Wenya Xu, Jie Chen, Tie Liu, Zeqing Song, Gang Liu Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Genetics | Legislation | Lung Cancer | Molecular Biology | Stem Cell Therapy | Stem Cells | Study